Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry

1. Alonso-Dominguez,J.M.
2. Castaño-Bonilla,T.
3. Gil,C.
4. Serrano-Lopez,J.
5. Martinez-Sanchez,P.
6. Herrera,P.
7. Garcia-Boyero,R.
8. Rodriguez-Arboli,E.
9. Brioso-Infante,J.
10. Benavente,C.
11. Lavilla-Rubira,E.
12. Tormo,M.
13. Sayas-Lloris,M.J.
14. Lainez-Gonzalez,D.
15. Serrano-Lopez,J.
16. Amigo,M.L.
17. Algarra,L.
18. Unamunzaga,A.
19. Alonso-Alonso,J.M.
20. Garcia-Garay,M.C.
21. Callejas-Charavia,M.
22. Roldan-Perez,A.
23. Cornago-Navascues,J.
24. Valero-Nuñez,M.
25. Alfonso-Pierola,A.
26. Perez-Santaolalla,E.
27. Sobas,M.
28. Romero-Riquelme,M.
29. Lopez,M.
30. Galvez,K.
31. Rodríguez-Veiga,R.
32. Barragan,E.
33. Ayala,R.
34. Solana-Altabella,A.
35. Lloret-Madrid,P.
36. Montesinos,P.
37. Show all authors +